Ken Griffin acquired 66.6 Thousand Mirati Therapeutics shares worth $3.91 Million. That's 0.00% of their equity portfolio (1697th largest holding). The investor owns Inf% of the outstanding Mirati Therapeutics stock. The first Mirati Therapeutics trade was made in Q3 2015. Since then Ken Griffin bought shares 39 more times and sold shares on 35 occasions. The investor's estimated purchase price is $5.44 Million, resulting in a loss of 28%.